This disclosure relates in general to fortifying breast milk, such as by concentrating nutrients within breast milk, in particular for premature babies.
Premature babies often require supplements to add nutrients to expressed human breast milk. Available supplements contain cow's milk protein and/or soy. One human milk fortifier available is made with pooled human milk that is sterilized, destroying some of the nutrients found in fresh expressed human milk. These supplements are the first foreign substances introduced to a baby's gut. The risk of intolerance of traditionally fortified feedings is most notable for the potential development of necrotizing enterocolitis, which can lead to gut damage and even death.
The teachings herein allow for fortification (e.g., through concentration) of a mother's own milk for her premature or sick baby to the prescribed nutrient density required for continued growth and development. Bedside use is possible, and the addition of foreign nutrients and heat processing may be avoided. The concentration of immunoglobulin and other unique nutrients that are provided in a mother's milk for her own baby is possible without external pressure and via forward osmosis to protect the fragile nutrients in the breast milk that can be damaged even by shaking the liquid too forcefully. The use of a forward osmotic membrane without nitrates allows for conservation of the immunoglobulin on the nutrient concentration side of the membrane and only water passes via forward osmosis to the other side of the membrane. The process is time sensitive for nutrient concentration and the higher concentration of nutrients on the waste side allows for the osmotic draw of water.
According to the teachings herein, one method described herein includes placing, into contact with a quantity of un-concentrated, expressed human milk, a forward osmotic membrane separating a material exhibiting an osmotic draw property from the quantity of un-concentrated, expressed human milk to draw water from the quantity of un-concentrated, expressed human milk to form concentrated human milk, and withdrawing the forward osmotic membrane from contact with the concentrated human milk when the concentrated human milk reaches a desired nutrient level.
An apparatus described herein includes a first sheet of material comprising a forward osmotic membrane, a second sheet of material sealed to the first sheet of material about a common outer perimeter thereof, the first sheet of material arranged so that water can traverse the forward osmotic membrane to an interior of the first and second sheets, and a dry carbohydrate within the interior of the first and second sheets exhibiting an osmotic draw property to draw water from un-concentrated, expressed human milk to form concentrated human milk.
Variations in these and other embodiments of the invention are described hereinafter.
One example of an apparatus incorporating the teachings herein is shown in
Forward osmotic membrane 104 may form a pouch 106 within receptacle 102 that is filled with a draw material such as a dry carbohydrate or mix of dry carbohydrates that will draw (e.g., pure) water from the milk and hold that water within the contours of pouch 106 and forward osmotic membrane 104. In one implementation, forward osmotic membrane 104 uses sucrose as the draw material. A filler material may be used to support the draw material and such material is not critical as long as it is inert to the expressed breast milk and designated as safe for contact with food. In one desirable implementation, pouch 106 is expandable as water is pulled across forward osmotic membrane 104 and into the draw material. In this implementation, forward osmotic membrane 104 forms pouch 106 with a second sheet of expandable material sealed with forward osmotic membrane 104. In other implementations, pouch 106 is not expandable. That is, forward osmotic membrane 104 forms pouch with a second sheet of non-expandable material sealed with forward osmotic membrane 104 such that pouch 106 is sized for the amount of water it is expected to hold. In either case, the second sheet is formed of a material that is designated as safe for contact with food. Further details of the forward osmotic membrane and another embodiment of a pouch formed therewith are discussed in detail with respect to
Referring again to
The apparatus may be used to concentrate expressed human milk from 20 kilocalories (kcal) per ounce to 24 kcal per ounce. Bottle 100 may be filled with up to 30 milliliters (ml) of milk and inverted. Pouch 106 of forward osmotic membrane 104 expands to fill receptacle 102. Once water is drawn into the pouch 106 sufficient to fill receptacle 102, the remaining breast milk has the desired concentrated level of nutrients. In another implementation, the filtering may be timed as discussed below. Bottle 100 can then be inverted such that receptacle 102 may be unscrewed and discarded as waste. Alternatively, pouch 106 may be discarded such that receptacle 102 is reusable with a new pouch 106 attached thereto. A nipple may then be screwed on to the threads of bottle 100 to feed an infant. The resulting liquid may also be moved to another delivery device for ingestion by an infant or other individual needing the nourishment.
In another implementation, forward osmotic membrane 104 is fitted across and secured to receptacle 102 by any number of techniques to seal draw material within receptacle 102. In this implementation, forward osmotic membrane 104 does not have an opposing second sheet forming pouch 106. The filtering may occur until the level of liquid within receptacle 102 that was drawn into the draw material reaches a level expected to produce a desired concentration of nutrients in the milk remaining within bottle 100, or until a time limit expires.
Measurement of the breast milk and the draw material may provide an exact measure of the concentration of nutrients after removal of the water.
There is potential for adaptation of this system to use in larger operations such as breast milk banks for both babies and human milk used for therapeutic feeding such as with intestinal transplant and other immunocompromised patients.
Bottle 100 and receptacle 102 may be varied in size and shape to allow use of different sizes as needed to concentrate different amounts of milk.
The forward osmosis process of concentrating expressed human milk described herein may be used with a single use/disposable forward osmotic membrane or with reusable forward osmotic membranes depending on if there is a single user and if the receptacle for the draw material/carbohydrate is replaceable and sanitation is feasible.
In yet another implementation, and regardless of whether pouch 106 is formed of an expanding material or non-expanding material with forward osmotic membrane 104, forward osmotic membrane 104 may be formed in the shape of a teabag and dropped into a container of un-concentrated, expressed milk. That is, forward osmotic membrane 104 is not attached for use with receptacle 102. It could be, for example, in the shape of a teabag. Once forward osmotic membrane 104 has removed the desired amount of water, it may be removed from the more concentrated breast milk. This implementation is described in more detail with respect to
One embodiment of a pouch that may be used with either the apparatus of
At step 204, the storage packet size is selected. The size may be selected in conjunction with the selection of the amount of draw material in step 202 and may be dictated by the application, such as the size of the container in which the milk will be processed. This would be bottle 100 in one example.
In the embodiment described above, pouch 106 is formed of a single forward osmotic membrane 104. At steps 206 to 210, a pouch 300 such as that shown in
Possible forward osmotic membranes are available from Hydration Technology Innovations, LLC of Albany, Oreg., within the OsMem FO family of membrane products. The laminate film is optional and may be used for protection in shipping or for structural support, etc. Where a laminate film is desired or required, it may be formed of a number of materials both safe for use with food products and permeable to liquid. Alternatively, the laminate film may be impermeable to liquid and removed before use of pouch 300. In one embodiment, laminate sheets 306, 308 may be a laminate comprising, for example, a high-density polyethylene (HDPE), low-density polyethylene (LDPE) or medium-density polyethylene (MDPE) resin or ethylene polymers approved for use in the manufacture of articles intended for contact with food.
After forming the pocket in step 206, process 200 advances to step 208. The opening of the pocket formed by sheets 302-308 is filled with draw material 312 at step 208. Examples of draw material 312 are described above. Once the pocket is filled with draw material 312, it is sealed to form the pouch 300. Optionally, pouch 300 is sealed within a thermoplastic resin for transportation and storage.
In the embodiment described above, pouch 106 is formed of a single forward osmotic membrane 104, and pouch 300 is formed of two sheets of forward osmotic membrane 104. Pouch 300 may, however, be formed of a single forward osmotic membrane 104 folded over itself so as to form the opening for draw material 312.
A process 400 of using pouch 300 is described with respect to
Once the limit is reached at step 406, process 400 advances to step 408 where pouch 300 is removed from the now concentrated milk. Process 400 then ends.
Experimental results show the usefulness and efficacy of the teachings herein.
In a study to test the timing of the water draw, a 3 in×3 in forward osmosis pouch formed with two sheets of a forward osmotic membrane and filled with 10 g of sucrose as described with respect to
Next, human milk sample studies were performed. In one test, two 3.5 in×3.5 in forward osmosis pouches were used. Each was formed with two sheets of the same forward osmotic membrane used in the cow's milk test, and each was filled with 20 g of sucrose. The pouches were rinsed in hot water for 15 min before use to remove the glycerine, although this step is not necessary. Each pouch initially weighed 22 gm, which weight increased by 10 gm at the end of the rinse. The increase weight per pouch was due to the draw of water across the forward osmotic membranes and into the pouch during the rinse.
Two pouches were added to 235 ml of expressed human milk. They were soaked for 3.25 hours in the milk stored in a refrigerator at 34 degrees Fahrenheit in a covered container. After the soak, the two pouches were removed and weighed. The milk remaining in the sample demonstrated low water removal—the amount of water removed was insufficient to achieve the desired nutrient levels in the concentrated milk. Due to this low water removal, a third 3.5 in×3.5 in forward osmosis pouch, also formed with two sheets of the same forward osmotic membrane and filled with 20 g of sucrose as described with respect to
The third pouch was removed at the end of the soak after removing the milk from the refrigerator. The total water removed by all three pouches was 29 ml. Fluid lost in processing was 10 ml. After processing, concentrated (processed) milk in the amount of 196 ml was analyzed for nutrient and glycerine content. A 120 ml control sample of un-concentrated (unprocessed), expressed human milk to which no filtering was applied was analyzed for nutrient content.
Results of the comparison are produced below as Table 1.
Ash, Chloride, Dietary Fiber, Moisture, Protein, Saturated Fat, Cholesterol, Phosphorus, Trans Fat and Vitamin C were all measured according to the applicable Official Methods of Analysis of AOAC INTERNATIONAL (OMA). Vitamin A, Iron and Sodium were measured according to known testing (e.g., WRE) methods. Sugars were measured according to a method compliant with both OMA and WRE. Calcium was measured according to the Environmental Protection Agency (EPA) 6020 method.
As can be seen from the test results, desirable increases in Calories (caloric content), Protein, Saturated Fat, Sugars, Calcium, Sodium and Carbohydrates resulted, with little change in other content characteristics except for Phosphorus. It is believed that the reduction in Phosphorus is an error. Glycerin content was negligible, and this result is not expected to change even when the optional rinsing step does not occur.
From the studies, it was noted that the lower temperature used during the soaking/filtering step for the human milk samples as compared to that used for the cow's milk samples notably slowed the water draw from the samples. An increased amount of draw material and/or a higher temperature during the soaking/filtering step would promote faster milk concentration by forward osmosis. Increase in the surface area and/or overall size of the pouch beyond what is needed to enclose the draw material is expected to have a negligible effect on the process and results, if any.
As mentioned, the temperatures used in the testing herein were room temperature (up to 77° F. or 25° C.) and 37° F. Higher temperatures are possible to speed up the process, but there may result in a corresponding reduction in the storage life of the milk. For example, room temperature storage of breast milk is not recommended for more than 6-8 hours. (See Academy of Breastfeeding Medicine, “Clinical Protocol Number #8: Human Milk Storage Information for Home Use for Healthy Full Term Infants,” 2004 (Princeton, N.J.)). Refrigerator temperatures are often up to 39° F. or 4° C., and storage of five days is possible. An insulated cooler bag can keep the milk fresh for 24 hours at temperatures of up to 39° F. Milk stored for longer durations at the temperatures described is safe, but some of the lipids Even an increase in the temperature of the milk from 37° F. to 39° F. is expected to increase the speed of the soaking/filtering step. If the soaking/filtering step is done at room temperature, immediate use may be desirable.
While the invention has been described with certain embodiments, the scope of the invention is not so limited. The skilled artisan, provided with the teachings herein, would understand modifications and variations that fall within the scope of the appended claims.
This application claims priority to U.S. Provisional Application No. 61/923,542, filed Jan. 3, 2014, and to U.S. Provisional Application No. 62/050,898, filed Sep. 16, 2014, each of which is incorporated herein in its entirety by reference.
Number | Date | Country | |
---|---|---|---|
61923542 | Jan 2014 | US | |
62050898 | Sep 2014 | US |